424 / | HD | DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS |
|
184.1 | DF | ANTIGEN, EPITOPE, OR OTHER IMMUNOSPECIFIC IMMUNOEFFECTOR (E.G., IMMUNOSPECIFIC VACCINE, IMMUNOSPECIFIC STIMULATOR OF CELL-MEDIATED IMMUNITY, IMMUNOSPECIFIC TOLEROGEN, IMMUNOSPECIFIC IMMUNOSUPPRESSOR, ETC.) {15} |
204.1 | DF | .~ Virus or component thereof {13} |
225.1 | | .~.~ Hepatitis virus (e.g., infectious canine hepatitis virus, duck hepatitis virus, mouse hepatitis virus, etc.) {3} |
226.1 | DF | .~.~.~> Hepatitis A virus |
227.1 | DF | .~.~.~> Hepatitis B virus (e.g., hepatitis B surface antigen (HBsAg), pre-S region, hepatitis B core antigen (HBcAg), hepatitis B e-antigen, Dane particle, etc.) |
228.1 | DF | .~.~.~> Non-A, non-B hepatitis virus or hepatitis C virus |